IBRX icon

ImmunityBio

62 hedge funds and large institutions have $124M invested in ImmunityBio in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 32 increasing their positions, 10 reducing their positions, and 8 closing their positions.

Holders
62
Holders Change
Holders Change %
0%
% of All Funds
1.66%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
8
Increased
32
Reduced
10
Closed
8
Calls
$599K
Puts
$374K
Net Calls
+$225K
Net Calls Change
-$954K
Name Market Value Shares Shares
Change
Shares
Change %
Manulife (Manufacturers Life Insurance)
51
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$14K 2,277 -1,169 -34%
AIM
52
Acrospire Investment Management
Illinois
$14K 2,200 +1,500 +214%
UBS Group
53
UBS Group
Switzerland
$13K 2,200 -700 -24%
ClearBridge Investments
54
ClearBridge Investments
New York
$12K 2,000
BNP Paribas Financial Markets
55
BNP Paribas Financial Markets
France
$9.37K 1,506 +1,446 +2,410%
PNC Financial Services Group
56
PNC Financial Services Group
Pennsylvania
$9K 1,500
Barclays
57
Barclays
United Kingdom
$8K 1,362 +801 +143%
TRCT
58
Tower Research Capital (TRC)
New York
$5K 771 +723 +1,506%
Group One Trading
59
Group One Trading
Illinois
$4K 607
Creative Planning
60
Creative Planning
Kansas
$3K 500
TWA
61
TCI Wealth Advisors
Arizona
$1K 200
RIM
62
RS Investment Management
California
-1,113,237 Closed
Massachusetts Financial Services
63
Massachusetts Financial Services
Massachusetts
-183,368 Closed
Millennium Management
64
Millennium Management
New York
-23,685 Closed
LCM
65
Laurion Capital Management
New York
-19,600 Closed
Renaissance Technologies
66
Renaissance Technologies
New York
-16,700 Closed
HCM
67
Highbridge Capital Management
New York
-10,605 Closed
CG
68
Cutler Group
California
-400 Closed
ST
69
Spot Trading
Illinois
-303 Closed
Citadel Advisors
70
Citadel Advisors
Florida
Simplex Trading
71
Simplex Trading
Illinois
HR
72
Howe & Rusling
New York
$0 50